Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
With so many global regulation changes, staying informed is a challenge. Join other regulatory professionals as you navigate the gray together.
Updated by a group of distinguished regulatory experts, this new edition is a must-have handbook for regulatory professionals at all levels.
In light of the COVID-19 pandemic, the RAC Board has elected to offer online testing with live online proctoring this summer.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.
The RAPS store will be under maintenance Saturday, 13 June between 6 AM and 12 PM EST. Store functionality may be unavailable at times during this window. We apologize for any inconvenience caused during this time.
Posted 11 July 2012 | By
US states are facing the prospect of losing further access to the execution drug propofol after the UK's business secretary announced his intent to publish new export controls aimed at banning the export of the drug from the country.
The Guardian reports Business Secretary Vince Cable is set to publish the details of the proposal on Wednesday, 11 June 2012. "We are clear that the state should never be complicit in judiciary executions through the use of British drugs in lethal injections," said cable in a statement to the press.
The export ban on the drug comes just as some states are moving away from sodium thiopental-a barbiturate used to anesthetize patients before a succession of two additional drugs are used to execute a convicted prisoner-in favor of other anesthetizing agents, including propofol and pentobarbital.
Sodium thiopental has experienced widespread shortages as the result efforts by death penalty opponents, who have been working to disrupt the supply of the drug through import, export and quality regulations. The US Food and Drug Administration (FDA) has even found its authority to exercise enforcement discretion under fire, with a judge ruling in March 2012 that the agency was acting in an "callous" manner in violation of the law.
The strategy may ultimately be backfiring on death penalty opponents as some states are moving to institute single-drug execution methods involving a massive overdose of pentobarbital. The drug is difficult-though possible-to obtain, with all but one drug manufacturer-Oak Pharmaceuticals-choosing to discontinue the drug.
On 10 June, Texas' Department of Criminal Justice announced it would make the switch to pentobarbital after its supply of one of its execution drugs expired. Texas now joins Arizona, Idaho, Ohio and Washington in exclusively using pentobarbital for executions, reports The Associated Press. Other states use propofol, infamously blamed for the death of singing icon Michael Jackson, instead of pentobarbital.
Read more:
The Guardian - UK to ban export of drug approved for use in US executions
AP - Texas switches to 1-drug execution due to shortage
San Antonio Express-News - Official: Texas switches to 1 drug for executions due to shortage of other drug
FDA - Approved Suppliers of Pentobarbital
FDA - Approved Suppliers of Propofol
Read all Regulatory Focus articles on Sodium Thiopental
Tags: Pentobarbital, Propofol, Criminal, Sodium Thiopental, Latest News, UK, pharmaceutical, execution, drug
Regulatory Focus newsletters
All the biggest regulatory news and happenings.